Goldman Sachs Maintains Neutral on Baxter International, Raises Price Target to $21

Benzinga Newsdesk www.benzinga.com Positive 59.2%

Neg 0% Neu 0% Pos 59.2%

Goldman Sachs analyst David Roman maintains Baxter International (NYSE:BAX) with a Neutral and raises the price target from $19 to $21.